137 related articles for article (PubMed ID: 30848975)
1. Complications and hospital costs during hematopoietic stem cell transplantation for non-Hodgkin lymphoma in the United States.
Cho SK; McCombs J; Punwani N; Lam J
Leuk Lymphoma; 2019 Oct; 60(10):2464-2470. PubMed ID: 30848975
[TBL] [Abstract][Full Text] [Related]
2. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample.
Jones JA; Qazilbash MH; Shih YC; Cantor SB; Cooksley CD; Elting LS
Cancer; 2008 Mar; 112(5):1096-105. PubMed ID: 18286506
[TBL] [Abstract][Full Text] [Related]
3. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Maloney DG
Leuk Lymphoma; 2003; 44 Suppl 3():S99-105. PubMed ID: 15202532
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center.
Molina A; Popplewell L; Kashyap A; Nademanee A
Clin Transpl; 2000; ():317-42. PubMed ID: 11512326
[TBL] [Abstract][Full Text] [Related]
6. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
Yu J; Parasuraman S; Shah A; Weisdorf D
Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):345-355.e7. PubMed ID: 31014757
[TBL] [Abstract][Full Text] [Related]
9. Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.
Jerjis S; Croockewit S; Muus P; Schaap N; Preijers F; de Witte T
Leuk Lymphoma; 1999 Dec; 36(1-2):33-43. PubMed ID: 10613448
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine.
Amer R; Salameh H; Mosleh S; Abu-Taha A; Hamayel H; Enaya A; Adas A; Khursani A; Wild-Ali M; Mousa T; Battat M; Daifallah A; Koni A; Shawahna R
BMC Infect Dis; 2022 Sep; 22(1):725. PubMed ID: 36071381
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
Bhatt VR; Vose JM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
[TBL] [Abstract][Full Text] [Related]
12. Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?
Ho AY; Pagliuca A
Hematology; 2002 Dec; 7(6):345-54. PubMed ID: 12475739
[TBL] [Abstract][Full Text] [Related]
13. Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.
Bierman PJ; Phillips GL
Cancer Treat Res; 2009; 144():357-97. PubMed ID: 19779882
[No Abstract] [Full Text] [Related]
14. Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis.
Zhou J; Nutescu EA; Han J; Calip GS
J Cancer Surviv; 2020 Jun; 14(3):294-304. PubMed ID: 31897877
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
[TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma.
Dogu MH; Çagirgan S; Ocakci S; Kaya AH; Ilkkilic K; Sanli NM; Kahraman S; Eren R; Tekgunduz E; Hacioglu S; Kaynar L; Erkurt MA; Altuntas F
Transfus Apher Sci; 2017 Dec; 56(6):814-818. PubMed ID: 29153347
[TBL] [Abstract][Full Text] [Related]
17. The Cost of Hematopoietic Stem-Cell Transplantation in the United States.
Broder MS; Quock TP; Chang E; Reddy SR; Agarwal-Hashmi R; Arai S; Villa KF
Am Health Drug Benefits; 2017 Oct; 10(7):366-374. PubMed ID: 29263771
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
19. Impact of Frailty on Hospital Outcomes Among Patients with Lymphoid Malignancies Receiving Autologous Hematopoietic Stem Cell Transplantation in the United States.
Rubens M; Cristian A; Ramamoorthy V; Ruiz M; Saxena A; McGranaghan P; Tonse R; Veledar E
Clin Lymphoma Myeloma Leuk; 2022 Jul; 22(7):e427-e434. PubMed ID: 35027337
[TBL] [Abstract][Full Text] [Related]
20. The allogeneic effect in non-Hodgkin's lymphoma.
Goldstone AH; Kottaridis PD
Leuk Lymphoma; 2003; 44 Suppl 3():S91-7. PubMed ID: 15202531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]